Analyzing New Study on GLP-1 Medications
Fox News senior medical analyst Dr. Marc Siegel recently discussed a study from the University of California San Diego. The study examines GLP-1 weight loss medications and their effect on the biological aging process. Dr. Siegel highlighted potential cardiovascular and neurological benefits, as well as side effects involving digestion and thyroid function.
Potential Risks and Findings
Researchers have linked GLP-1 medications to a rare brain condition, Wernicke encephalopathy, in 15 reported cases. These were identified through the FDA’s Adverse Event Reporting System, published literature, and medical centers. This disorder, caused by severe vitamin B1 deficiency, was mostly associated with medications like semaglutide and tirzepatide, sold under brand names such as Ozempic and Wegovy.
“This study shows a rare occurrence of a severe condition among a large population of GLP-1 users,” said Karthik Achari, founder of PepMD.
Vitamin B1 deficiencies can lead to confusion, balance issues, and vision problems. Although the study suggests a link, it cannot conclusively prove the medications cause this condition.
Expert Perspectives
Karthik Achari emphasized the rarity of the condition, with only 15 cases among millions of GLP-1 users. He pointed out that GLP-1 drugs reduce appetite but not the body’s actual nutritional needs.
Erin Palinski-Wade, a nutritionist, advised including proper nutrition and hydration as part of treating with GLP-1. Undereating essential nutrients can lead to dehydration and kidney problems, especially when accompanied by ongoing gastrointestinal issues.
Both experts agreed on the need for medical guidance if symptoms persist and called for more research. Patients should not discontinue GLP-1 medications without consulting their doctors.
Conclusion
The study shines a light on a rare but serious health condition that may affect a small subset of GLP-1 medication users. It underscores the importance of monitoring nutritional intake and consulting healthcare professionals when symptoms arise.